CTSB and Parkinson disease: Our findings here argue that the mechanism by which CTSB variants influence PD risk could be mediated either directly through the ability of catB to cleave and degrade α-syn, which has been previously reported [18–20] or due to the critical role of CTSB in maintaining lysosome function more broadly.